We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-4.93%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$98.8B
AUM Growth
-$3.4B
Cap. Flow
+$2.69B
Cap. Flow %
2.72%
Top 10 Hldgs %
24.29%
Holding
4,219
New
200
Increased
1,781
Reduced
1,776
Closed
283
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ICL icon
3226
ICL Group
ICL
$6.96B
$278K ﹤0.01%
+34,031
New +$318K
IFLN
3227
Invesco Bloomberg Enhanced Fallen Angels ETF
IFLN
$307M
$278K ﹤0.01%
16,923
+1,504
+10% +$26K
SDIV icon
3228
Global X SuperDividend ETF
SDIV
$1.21B
$278K ﹤0.01%
12,273
-569
-4% -$15.2K
TBLU
3229
Tortoise Global Water ETF
TBLU
$57.9M
$278K ﹤0.01%
8,443
-119
-1% -$4.42K
CCSI icon
3230
Consensus Cloud Solutions
CCSI
$717M
$277K ﹤0.01%
5,863
-197
-3% -$10.1K
EMLC icon
3231
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.79B
$277K ﹤0.01%
12,146
-27,684
-70% -$663K
AVDV icon
3232
Avantis International Small Cap Value ETF
AVDV
$19.9B
$276K ﹤0.01%
5,801
+55
+1% +$2.92K
CVX icon
3233
CALL
Chevron
CVX
$388B
$276K ﹤0.01%
23,800
+12,000
+102% +$1.83M
KDNY
3234
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$276K ﹤0.01%
14,057
+339
+2% +$6.8K
HIBB
3235
DELISTED
Hibbett, Inc. Common Stock
HIBB
$276K ﹤0.01%
5,550
-523
-9% -$27.5K
NTRA icon
3236
Natera
NTRA
$44.8B
$275K ﹤0.01%
+6,275
New +$299K
VRNT
3237
DELISTED
Verint Systems
VRNT
$275K ﹤0.01%
8,200
-11,522
-58% -$502K
CDMO
3238
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$275K ﹤0.01%
14,381
HLIT icon
3239
Harmonic Inc
HLIT
$1.42B
$274K ﹤0.01%
+21,002
New +$227K
PHR icon
3240
Phreesia
PHR
$780M
$274K ﹤0.01%
10,761
-209
-2% -$5.22K
PKX icon
3241
POSCO
PKX
$17.1B
$274K ﹤0.01%
7,497
-275
-4% -$12.3K
DNMR
3242
DELISTED
Danimer Scientific, Inc.
DNMR
$272K ﹤0.01%
2,306
+251
+12% +$44.7K
FLTR icon
3243
VanEck IG Floating Rate ETF
FLTR
$3.04B
$271K ﹤0.01%
10,908
-13,940
-56% -$346K
MFG icon
3244
Mizuho Financial
MFG
$134B
$271K ﹤0.01%
122,690
-23,210
-16% -$54K
ONLN icon
3245
ProShares Online Retail ETF
ONLN
$65M
$271K ﹤0.01%
+9,082
New +$317K
HAYW icon
3246
Hayward Holdings
HAYW
$3.24B
$270K ﹤0.01%
30,409
+564
+2% +$6.63K
LMDX
3247
DELISTED
LumiraDx Limited Common Shares
LMDX
$270K ﹤0.01%
+264,818
New +$439K
ALX
3248
Alexander's
ALX
$1.4B
$269K ﹤0.01%
1,287
-38
-3% -$8.98K
XOM icon
3249
CALL
ExxonMobil
XOM
$652B
$269K ﹤0.01%
13,700
MAV
3250
DELISTED
Pioneer Municipal High Income Advantage Fund
MAV
$267K ﹤0.01%
35,404
-1,403
-4% -$12.3K

Similar funds

Raymond James & Associates's Q3 2022 Portfolio in Review

As of Q3 2022, Raymond James & Associates held 4,219 positions worth $98.8B, down 3.3% from $102B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q3 2022 filing shows 200 new, 1,781 increased, 1,776 reduced and 283 closed positions. Its largest new stake was JPMorgan Nasdaq Equity Premium Income ETF: 332,653 shares worth $13.9M. The largest sale was iShares Core 1-5 Year USD Bond ETF, an estimated $255M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q3 2022 buy was JPMorgan Nasdaq Equity Premium Income ETF: 332,653 shares worth $13.9M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q3 2022, an estimated $620M increase.
  • Raymond James & Associates's biggest Q3 2022 reduction was iShares Core 1-5 Year USD Bond ETF, cutting an estimated $255M.
  • Raymond James & Associates fully exited CDK Global, Inc. in Q3 2022, selling an estimated $36M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $98.8B portfolio in Q3 2022.
  • Raymond James & Associates opened 200 new positions and closed 283 in Q3 2022.
  • Raymond James & Associates's portfolio value fell 3.3% quarter-over-quarter to $98.8B.

Based on Raymond James & Associates's 13F filing for Q3 2022, filed 25 Oct 2022.